Evidence Review & Consensus: Dialkylcarbamoyl Chloride (DACC)–Coated Wound Dressings
Summary: A Wounds International expert consensus document evaluates the clinical role of DACC-coated wound dressings, which bind microorganisms through hydrophobic interactions rather than releasing active antimicrobial agents. This mode of action reduces resistance risk and preserves host tissue, offering a unique option for wounds at risk of infection.
Key Highlights:
- Mechanism: DACC attracts and irreversibly binds hydrophobic microbes, physically removing them when the dressing is changed, rather than killing them chemically.
- Evidence base: Systematic reviews and clinical studies support effectiveness in reducing bioburden and promoting healing in diabetic foot ulcers, pressure ulcers, venous leg ulcers, surgical wounds, and burns.
- Safety: No cytotoxicity; suitable for fragile tissue. Dressings are biocompatible and safe across a wide range of wound types and patient populations.
- Consensus: The panel positions DACC dressings as a valuable first-line tool for infection prevention and adjunctive therapy in wounds with high microbial burden or delayed healing.
- Health economics: By reducing infection rates and antibiotic use, DACC dressings may contribute to lower overall treatment costs and improved antimicrobial stewardship.
Read the full consensus document on Wounds International
Keywords:
DACC wound dressing,
antimicrobial stewardship,
bioburden control,
diabetic foot ulcer,
venous leg ulcer,
pressure ulcer